ResearcherCentre National de la Recherche ScientifiqueNo recent work listed
Victoire Gouirand
Matched on ORCID iD 0000-0002-2666-0061; OpenAlex author ID A5072974831. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 20
2015: 1 paper · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper
Papers 4
- Ketogenic HMG-CoA lyase and its product β-hydroxybutyrate promote pancreatic cancer progression. Co-author DOI 10.15252/embj.2021110466↗
- Fountain of youth of pancreatic cancer cells: the extracellular matrix. Co-author DOI 10.1038/s41420-017-0004-7↗
- Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions. Co-author DOI 10.1038/ncomms16031↗
- Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma. Co-author DOI 10.1073/pnas.1421601112↗
Closest collaborators
The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Sophie Vasseur · 4 shared papers, 2015–2022 · strength 0.38
- Paper Fountain of youth of pancreatic cancer cells: the extracellular matrix. DOI 10.1038/s41420-017-0004-7↗
- Paper Ketogenic HMG-CoA lyase and its product β-hydroxybutyrate promote pancreatic cancer progression. DOI 10.15252/embj.2021110466↗
- Paper Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions. DOI 10.1038/ncomms16031↗
- Fabienne Guillaumond · 3 shared papers, 2015–2022 · strength 0.20
- Paper Ketogenic HMG-CoA lyase and its product β-hydroxybutyrate promote pancreatic cancer progression. DOI 10.15252/embj.2021110466↗
- Paper Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions. DOI 10.1038/ncomms16031↗
- Paper Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreat… DOI 10.1073/pnas.1421601112↗
- Richard Tomasini · 3 shared papers, 2015–2022 · strength 0.20
- Paper Ketogenic HMG-CoA lyase and its product β-hydroxybutyrate promote pancreatic cancer progression. DOI 10.15252/embj.2021110466↗
- Paper Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions. DOI 10.1038/ncomms16031↗
- Paper Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreat… DOI 10.1073/pnas.1421601112↗
- Juan Iovanna · 3 shared papers, 2015–2022 · strength 0.20
- Paper Ketogenic HMG-CoA lyase and its product β-hydroxybutyrate promote pancreatic cancer progression. DOI 10.15252/embj.2021110466↗
- Paper Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions. DOI 10.1038/ncomms16031↗
- Paper Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreat… DOI 10.1073/pnas.1421601112↗
- Tristan Gicquel · 2 shared papers, 2017–2022 · strength 0.17
- Jared R. Mayers · 2 shared papers, 2017–2022 · strength 0.17
- Matthew G. Vander Heiden · 2 shared papers, 2017–2022 · strength 0.17
- Jérémy Nigri · 2 shared papers, 2015–2022 · strength 0.15
- Evan Chen Lien · 1 shared paper, 2022 · strength 0.11
- François Bertucci · 1 shared paper, 2022 · strength 0.11
- Emilie Jaune · 1 shared paper, 2022 · strength 0.11
- Julie Leca · 1 shared paper, 2022 · strength 0.11
- Nelson Dusetti · 1 shared paper, 2022 · strength 0.11
- Julie Roques · 2 shared papers, 2015–2017 · strength 0.09
- Paper Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions. DOI 10.1038/ncomms16031↗
- Paper Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreat… DOI 10.1073/pnas.1421601112↗
- Orianne Olivares · 2 shared papers, 2015–2017 · strength 0.09
- Paper Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions. DOI 10.1038/ncomms16031↗
- Paper Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreat… DOI 10.1073/pnas.1421601112↗
- Véronique Secq · 1 shared paper, 2017 · strength 0.05
- Dominique Lombardo · 1 shared paper, 2017 · strength 0.05
- Céline Loncle · 1 shared paper, 2015 · strength 0.04
- Odile Gayet · 1 shared paper, 2015 · strength 0.04
- Mehdi Ouaïssi · 1 shared paper, 2015 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.